InsidersTradesSigma
Total declarations
Companies
▲ Purchases (14 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
14
Disclosed sells
2
T+90 hit rate
20%
T+90 mean return
-7.4%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Apeiron Investment Group Ltd.. Director active across 4 companies, notably ATAI Life Sciences N.V.. Cumulatively, 17 reports have been logged. Split: 14 buys · 2 sells. Total volume traded: €48.5m. Activity tracked since 22 June 2021. The latest transaction was disclosed on 24 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations17 total
1,800,000 shares@ US$1.405.2% of flowCommon SharesSEC:0000950170-25-043942:0
Ideal exit: 19 Dec 2025 (T+270)
10,835,718 shares@ US$2.1048.5% of flowCommon SharesSEC:0000950170-25-023436:0
Ideal exit: 11 Nov 2025 (T+270)
90,806 shares@ US$0.33100.0% of flowOrdinary SharesSEC:0000950170-24-113344:0
251,881 sharesCommon StockSEC:0000950170-24-026885:0
2,485,923 shares@ US$1.58100.0% of flowCommon StockSEC:0000921895-23-001420:0
1,214,297 shares@ US$1.3183.3% of flowCommon SharesSEC:0000899243-23-009973:0
Ideal exit: 24 Dec 2023 (T+270)
1,100 shares@ US$1.6150.0% of flowCommon StockSEC:0000921895-23-000615:0
Ideal exit: 20 Nov 2023 (T+270)
67,703 shares@ US$5.08860.021% mcap1.6% of flowCommon SharesSEC:0000899243-22-016301:0
Ideal exit: 15 Jan 2023 (T+270)
34,700 shares@ US$4.45790.0099% mcap0.8% of flowCommon SharesSEC:0000899243-22-016117:0
Ideal exit: 23 Jan 2023 (T+270)
46,207 shares@ US$4.68820.014% mcap1.1% of flowCommon SharesSEC:0000899243-22-015852:0
Ideal exit: 21 Jan 2023 (T+270)
52,820 shares@ US$4.8270.016% mcap1.2% of flowCommon SharesSEC:0000899243-22-015653:0
Ideal exit: 17 Jan 2023 (T+270)
54,322 shares@ US$5.11130.017% mcap1.3% of flowCommon SharesSEC:0000899243-22-015168:0
Ideal exit: 13 Jan 2023 (T+270)
4,967 shares@ US$5.190.0016% mcap0.1% of flowCommon SharesSEC:0000899243-22-014963:0
Ideal exit: 9 Jan 2023 (T+270)
55,197 shares@ US$4.88360.017% mcap1.3% of flowCommon SharesSEC:0000899243-22-014797:0
Ideal exit: 7 Jan 2023 (T+270)
57,689 shares@ US$4.81270.017% mcap1.3% of flowCommon SharesSEC:0000899243-22-014575:0
Ideal exit: 3 Jan 2023 (T+270)
700,000 shares@ US$15.0019.6% of flowCommon SharesSEC:0000899243-21-025738
Ideal exit: 19 Mar 2022 (T+270)
700,000 shares@ US$15.000.59% mcap45.6% of flowCommon SharesSEC:0000899243-21-025738:0
Ideal exit: 19 Mar 2022 (T+270)
17 of 17 declarations
About Apeiron Investment Group Ltd.
Apeiron Investment Group Ltd. is a director and insider at ATAI Life Sciences N.V.
